​CommInsure Allocation To GAM Another Sign Of Investors Embracing ARP

CommInsure, one of Australia’s leading life insurance companies, plans to invest more than AUD300 million into GAM’s Systematic Alternative Risk Premia product, another sign of an institutional investor embracing the benefits of ARP. As reported by EQDerivatives in its last magazine and its special report on alternative risk premia, investors are increasingly accessing ARP funds as institutional investors hunt a transparent and liquid framework and ultimately improve risk-adjusted returns. In Australia, particularly, CommInsure’s move to invest in a mandate that will manage a diversified portfolio of risk premia from GAM is further evidence of the increased take-up of alternative risk premia, not just from superannuation funds, but from the wider institutional investor community in the country. This is something EQDerivatives will seek to take a deeper dive into in our upcoming client alternative risk premia market mapping project and the upcoming Australia EQD conference.